Overcoming immune tolerance to cancer by heat shock protein vaccines

Molecular Cancer Therapeutics

Volumn 1, Issue 12, 2002, Pages 1147-1151

  Liu, Bei ^a   DeFilippo, Anna M ^a   Li, Zihai ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; HEAT SHOCK PROTEIN;

BIOLOGICAL MODEL; CHEMISTRY; DENDRITIC CELL; HUMAN; IMMUNOLOGY; METABOLISM; NEOPLASM; REVIEW; T LYMPHOCYTE;

CANCER VACCINES; DENDRITIC CELLS; HEAT-SHOCK PROTEINS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; T-LYMPHOCYTES;

EID: 0037670279     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (73)

1. Lindquist, S. The heat-shock response. Annu. Rev. Biochem., 55: 1151-1191, 1986. (Pubitemid 16070798)
2. Feder, M. E., and Hofmann, G. E. Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annu. Rev. Physiol., 61: 243-282, 1999. (Pubitemid 29143171)
3. Morimoto, R. I., and Santoro, M. G. Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat. Biotechnol., 16: 833-838, 1998. (Pubitemid 28405852)
4. Li, Z. Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines. Semin. Immunol., 9: 315-322, 1997. (Pubitemid 28077729)
5. Li, Z. The roles of heat shock proteins in tumor immunity. Cancer Chemother. Biol. Response Modif., 19: 371-383, 2001.
6. Srivastava, P. K., Menoret, A., Basu, S., Binder, R. J., and McQuade, K. L. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity, 8: 657-665, 1998. (Pubitemid 28294512)
7. Srivastava, P. K., and Das, M. R. The serologically unique cell surface antigen of Zajdela ascitic hepatoma is also its tumor-associated transplantation antigen. Int. J. Cancer, 33: 417-422, 1984. (Pubitemid 14159040)
8. Srivastava, P. K., DeLeo, A. B., and Old, L. J. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl. Acad. Sci. USA, 83: 3407-3411, 1986. (Pubitemid 16043046)
9. Udono, H., and Srivastava, P. K. Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med., 178: 1391-1396, 1993. (Pubitemid 23277370)
10. Ullrich, S. J., Robinson, E. A., Law, L. W., Willingham, M., and Appella, E. A mouse tumor-specific transplantation antigen is a heat shock-related protein. Proc. Natl. Acad. Sci. USA, 83: 3121-3125, 1986. (Pubitemid 16042988)
11. Udono, H., and Srivastava, P. K. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol., 152: 5398-5403, 1994. (Pubitemid 24152988)
12. Basu, S., and Srivastava, P. K. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J. Exp. Med., 189: 797-802, 1999. (Pubitemid 29189684)
13. Nair, S., Wearsch, P. A., Mitchell, D. A., Wassenberg, J. J., Gilboa, E., and Nicchitta, C. V. Calreticulin displays in vivo peptide-binding activity and can elicit CTL responses against bound peptides. J. Immunol., 162: 6426-6432, 1999. (Pubitemid 29309363)
14. Wang, X. Y., Kazim, L., Repasky, E. A., and Subjeck, J. R. Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity. J. Immunol., 166: 490-497, 2001. (Pubitemid 32038468)
15. Blachere, N. E., Udono, H., Janetzki, S., Li, Z., Heike, M., and Srivastava, P. K. Heat shock protein vaccines against cancer. J. Immunother., 14: 352-356, 1993. (Pubitemid 23322757)
16. Nieland, T. J., Tan, M. C., Monne-van Muijen, M., Koning, F., Kruisbeek, A. M., and van Bleek, G. M. Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94. Proc. Natl. Acad. Sci. USA, 93: 6135-6139, 1996. (Pubitemid 26190816)
17. Ciupitu, A. M., Petersson, M., O'Donnell, C. L., Williams, K., Jindal, S., Kiessling, R., and Welsh, R. M. Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J. Exp. Med., 187: 685-691, 1998. (Pubitemid 28115184)
18. Kumaraguru, U., Gierynska, M., Norman, S., Bruce, B. D., and Rouse, B. T. Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection. J. Virol., 76: 136-141, 2002. (Pubitemid 33138999)
19. Zugel, U., Sponaas, A. M., Neckermann, J., Schoel, B., and Kaufmann, S. H. gp96-peptide vaccination of mice against intracellular bacteria. Infect. Immunol., 69: 4164-4167, 2001. (Pubitemid 32493345)
20. Sponaas, A. M., Zuegel, U., Weber, S., Hurwitz, R., Winter, R., Lamer, S., Jungblut, P. R., and Kaufmann, S. H. Immunization with gp96 from Listeria monocytogenes-infected mice is due to N-formylated listerial peptides. J. Immunol., 167: 6480-6486, 2001. (Pubitemid 33081582)
21. Diefenbach, A., Jensen, E. R., Jamieson, A. M., and Raulet, D. H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity. Nature (Lond.), 413: 165-171, 2001. (Pubitemid 32867877)
22. Kelly, J. M., Darcy, P. K., Markby, J. L., Godfrey, D. I., Takeda, K., Yagita, H., and Smyth, M. J. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol., 3: 83-90, 2002. (Pubitemid 34065622)
23. Banchereau, J., and Steinman, R. M. Dendritic cells and the control of immunity. Nature (Lond.), 392: 245-252, 1998. (Pubitemid 28155090)
24. Matzinger, P. Tolerance, danger, and the extended family. Annu. Rev. Immunol., 12: 991-1045, 1994. (Pubitemid 24140436)
25. Srivastava, P. K. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol., 2: 185-194, 2002.
26. Li, Z., Dai, J., Zheng, H., Liu, B., and Caudill, M. An integrated view of the roles and mechanisms of heat shock protein gp96-peptide complex in immune response. Front. Biosci., 7: 731-751, 2002.
27. Binder, R. J., Han, D. K., and Srivastava, P. K. CD91: a receptor for heat shock protein gp96. Nat. Immunol., 1: 151-155, 2000.
28. Basu, S., Binder, R. J., Ramalingam, T., and Srivastava, P. K. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity, 14: 303-313, 2001. (Pubitemid 32289294)
29. Zheng, H., Dai, J., Stoilova, D., and Li, Z. Cell surface targeting of heat shock protein gp96 induces dendritic cell maturation and antitumor immunity. J. Immunol., 167: 6731-6735, 2001. (Pubitemid 33144162)
30. Li, Z., Menoret, A., and Srivastava, P. Roles of heat-shock proteins in antigen presentation and cross- presentation. Curr. Opin. Immunol., 14: 45-51, 2002. (Pubitemid 34085106)
31. Melnick, J., Dul, J. L., and Argon, Y. Sequential interaction of the chaperones BiP and GRP94 with immunoglobulin chains in the endoplasmic reticulum. Nature (Lond.), 370: 373-375, 1994.
32. Randow, F., and Seed, B. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nat. Cell Biol., 3: 891-896, 2001. (Pubitemid 32952253)
33. Schild, H., and Rammensee, H. G. gp96-the immune system's Swiss army knife. Nat. Immunol., 1: 100-101, 2000.
34. Caudill, M. M., and Li, Z. HSPPC-96: a personalised cancer vaccine. Exp. Opin. Biol. Ther., 1: 539-547, 2001. (Pubitemid 33768668)
35. Srivastava, P. K. Immunotherapy of human cancer: lessons from mice. Nat. Immunol., 1: 363-366, 2000.
36. Srivastava, P. K. Do human cancers express shared protective antigens? Or the necessity of remembrance of things past? Semin. Immunol., 8: 295-302, 1996. (Pubitemid 26413870)
37. Castelli, C., Ciupitu, A. M., Rini, F., Rivoltini, L., Mazzocchi, A., Kiessling, R., and Parmiani, G. Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells. Cancer Res., 61: 222-227, 2001. (Pubitemid 32095721)
38. Belli, F., Testori, A., Rivoltini, L., Maio, M., Andreola, G., Sertoli, M. R., Gallino, G., Piris, A., Cattelan, A., Lazzari, I., Carrabba, M., Scita, G., Santantonio, C., Pilla, L., Tragni, G., Lombardo, C., Arienti, F., Marchianò, A., Bertolini, F., Cova, A., Lamaj, E., Ascani, L., Camerini, R., Corsi, M., Cascinelli, N., Lewis, J. J., Srivastava, P. K., and Parmiani, G. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide Complexes (Oncophage®). J. Clin. Oncol., in press, 2002.
39. Kappler, J. W., Roehm, N., and Marrack, P. T cell tolerance by clonal elimination in the thymus. Cell, 49: 273-280, 1987.
40. von Boehmer, H., and Kisielow, P. Self-nonself discrimination by T cells. Science (Wash. DC), 248: 1369-1373, 1990.
41. Heath, W. R., and Carbone, F. R. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol., 19: 47-64, 2001. (Pubitemid 32368029)
42. Bretscher, P., and Cohn, M. A theory of self-nonself discrimination. Science (Wash. DC), 169: 1042-1049, 1970.
43. Janeway, C. A., Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol., 54: 1-13, 1989.
44. Chambers, C. A., Kuhns, M. S., Egen, J. G., and Allison, J. P. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol., 19: 565-594, 2001. (Pubitemid 32368046)
45. Chen, L., Ashe, S., Brady, W. A., Hellstrom, I., Hellstrom, K. E., Ledbetter, J. A., McGowan, P., and Linsley, P. S. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell, 71: 1093-1102, 1992. (Pubitemid 23016545)
46. Pardoll, D. M. Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol., 13: 399-415, 1995.
47. Kirk, C. J., Hartigan-O'Connor, D., Nickoloff, B. J., Chamberlain, J. S., Giedlin, M., Aukerman, L., and Mule, J. J. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Cancer Res., 61: 2062-2070, 2001. (Pubitemid 32692028)
48. Vallera, D. A., Taylor, P. A., Aukerman, S. L., and Blazar, B. R. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2. Cancer Res., 53: 4273-4280, 1993. (Pubitemid 24146778)
49. Kwon, E. D., Hurwitz, A. A., Foster, B. A., Madias, C., Feldhaus, A. L., Greenberg, N. M., Burg, M. B., and Allison, J. P. Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. Proc. Natl. Acad. Sci. USA, 94: 8099-8103, 1997. (Pubitemid 27343783)
50. Baggers, J., Ratzinger, G., and Young, J. W. Dendritic cells as immunologic adjuvants for the treatment of cancer. J. Clin. Oncol., 18: 3879-3882, 2000.
51. Morse, M. A., Mosca, P. J., Clay, T. M., and Lyerly, H. K. Dendritic cell maturation in active immunotherapy strategies. Exp. Opin. Biol. Ther., 2: 35-43, 2002. (Pubitemid 34462459)
52. Tamura, Y., Peng, P., Liu, K., Daou, M., and Srivastava, P. K. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science (Wash. DC), 278: 117-120, 1997. (Pubitemid 27446289)
53. Udono, H., Levey, D. L., and Srivastava, P. K. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo. Proc. Natl. Acad. Sci. USA, 91: 3077-3081, 1994. (Pubitemid 24130178)
54. Manjili, M. H., Henderson, R., Wang, X. Y., Chen, X., Li, Y., Repasky, E., Kazim, L., and Subjeck, J. R. Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110. Cancer Res., 62: 1737-1742, 2002. (Pubitemid 34408496)
55. Yamazaki, K., Nguyen, T., and Podack, E. R. Cutting edge: tumor secreted heat shock-fusion protein elicits CD8 cells for rejection. J. Immunol., 163: 5178-5182, 1999.
56. Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., and Vile, R. G. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med., 4: 581-587, 1998. (Pubitemid 28237357)
57. Todryk, S., Melcher, A. A., Hardwick, N., Linardakis, E., Bateman, A., Colombo, M. P., Stoppacciaro, A., and Vile, R. G. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J. Immunol., 163: 1398-1408, 1999. (Pubitemid 29352760)
58. Gallucci, S., Lolkema, M., and Matzinger, P. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med., 5: 1249-1255, 1999. (Pubitemid 29535601)
59. Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., and Bhardwaj, N. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med., 191: 423-434, 2000.
60. Basu, S., Binder, R. J., Suto, R., Anderson, K. M., and Srivastava, P. K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol., 12: 1539-1546, 2000.
61. Somersan, S., Larsson, M., Fonteneau, J. F., Basu, S., Srivastava, P., and Bhardwaj, N. Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J. Immunol., 167: 4844-4852, 2001. (Pubitemid 33009712)
62. Kotera, Y., Shimizu, K., and Mule, J. J. Comparative analysis of necrotic and apoptotic tumor cells as a source of antigen(s) in dendritic cell-based immunization. Cancer Res., 61: 8105-8109, 2001. (Pubitemid 33091598)
63. Wiest, D. L., Bhandoola, A., Punt, J., Kreibich, G., McKean, D., and Singer, A. Incomplete endoplasmic reticulum (ER) retention in immature thymocytes as revealed by surface expression of "ER-resident" molecular chaperones. Proc. Natl. Acad. Sci. USA, 94: 1884-1889, 1997.
64. Gorza, L., and Vitadello, M. Reduced amount of the glucose-regulated protein GRP94 in skeletal myoblasts results in loss of fusion competence. FASEB J., 14: 461-475, 2000. (Pubitemid 30143165)
65. Altmeyer, A., Maki, R. G., Feldweg, A. M., Heike, M., Protopopov, V. P., Masur, S. K., and Srivastava, P. K. Tumor-specific cell surface expression of the-KDEL containing, endoplasmic reticular heat shock protein gp96. Int. J. Cancer, 69: 340-349, 1996. (Pubitemid 26298302)
66. Robert, J., Menoret, A., and Cohen, N. Cell surface expression of the endoplasmic reticular heat shock protein gp96 is phylogenetically conserved. J. Immunol., 163: 4133-4139, 1999. (Pubitemid 29474475)
67. Booth, C., and Koch, G. L. Perturbation of cellular calcium induces secretion of luminal ER proteins. Cell, 59: 729-737, 1989. (Pubitemid 19282880)
68. Seddiki, N., Nato, F., Lafaye, P., Amoura, Z., Piette, J. C., and Mazie, J. C. Calreticulin, a potential cell surface receptor involved in cell penetration of anti-DNA antibodies. J. Immunol., 166: 6423-6429, 2001. (Pubitemid 32440777)
69. Ogden, C. A., deCathelineau, A., Hoffmann, P. R., Bratton, D., Ghebrehiwet, B., Fadok, V. A., and Henson, P. M. C1q and mannose binding lectin engagement of cell surface calreticulin and cd91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med., 194: 781-796, 2001.
70. Asea, A., Kraeft, S. K., Kurt-Jones, E. A., Stevenson, M. A., Chen, L. B., Finberg, R. W., Koo, G. C., and Calderwood, S. K. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med., 6: 435-442, 2000. (Pubitemid 30208161)
71. Fujihara, S. M., and Nadler, S. G. Intranuclear targeted delivery of functional NF-κB by 70 kDa heat shock protein. EMBO J., 18: 411-419, 1999. (Pubitemid 29041949)
72. Triantafilou, K., Triantafilou, M., and Dedrick, R. L. A CD14-independent LPS receptor cluster. Nat. Immunol., 2: 338-345, 2001.
73. Stephanou, A., Latchman, D. S., and Isenberg, D. A. The regulation of heat shock proteins and their role in systemic lupus erythematosus. Semin. Arthritis Rheum., 28: 155-162, 1998. (Pubitemid 28563927)